Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMRN

IMMURON (IMRN) Stock Price, News & Analysis

IMMURON logo

About IMMURON Stock (NASDAQ:IMRN)

Key Stats

Today's Range
$1.85
$2.13
50-Day Range
$4.80
$5.61
52-Week Range
$1.50
$2.87
Volume
12,391 shs
Average Volume
70,440 shs
Market Capitalization
$15.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

IMMURON Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
6th Percentile Overall Score

IMRN MarketRank™: 

IMMURON scored higher than 6% of companies evaluated by MarketBeat, and ranked 925th out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for IMMURON are expected to decrease in the coming year, from ($0.02) to ($0.03) per share.

  • Price to Book Value per Share Ratio

    IMMURON has a P/B Ratio of 2.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.94% of the outstanding shares of IMMURON have been sold short.
  • Short Interest Ratio / Days to Cover

    IMMURON has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IMMURON has recently decreased by 10.03%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    IMMURON does not currently pay a dividend.

  • Dividend Growth

    IMMURON does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.94% of the outstanding shares of IMMURON have been sold short.
  • Short Interest Ratio / Days to Cover

    IMMURON has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IMMURON has recently decreased by 10.03%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for IMMURON this week, compared to 1 article on an average week.
  • MarketBeat Follows

    2 people have added IMMURON to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, IMMURON insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.01% of the stock of IMMURON is held by insiders.

  • Percentage Held by Institutions

    Only 0.12% of the stock of IMMURON is held by institutions.

  • Read more about IMMURON's insider trading history.
Receive IMRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMMURON and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMRN Stock News Headlines

Immuron Submits IMM-529 IND to FDA
Robinhood warning
A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fastest pace in history. CNBC calls it "the largest wealth creation spree in history." Yet 1 in 3 Americans now fear their financial situation is deteriorating. There's only one way to survive, says the man who predicted 2008 and 2020, but sadly it's already too late for many.tc pixel
Immuron Letter to Shareholders – Projects Update
See More Headlines

IMRN Stock Analysis - Frequently Asked Questions

IMMURON (IMRN) raised $6 million in an initial public offering (IPO) on Friday, June 9th 2017. The company issued 600,000 shares at $9.99 per share. Joseph Gunnar and Rodman & Renshaw (a unit of H.C. Wainwright & Co.) served as the underwriters for the IPO and WallachBeth Capital was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that IMMURON investors own include NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Gilead Sciences (GILD), AbbVie (ABBV), VBI Vaccines (VBIV), CRISPR Therapeutics (CRSP) and Dynavax Technologies (DVAX).

Company Calendar

Today
10/08/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
N/A
Current Symbol
NASDAQ:IMRN
CIK
1660046
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.10
Quick Ratio
4.19

Sales & Book Value

Annual Sales
$4.72 million
Price / Sales
3.22
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.78 per share
Price / Book
2.90

Miscellaneous

Outstanding Shares
6,710,000
Free Float
6,236,000
Market Cap
$15.20 million
Optionable
Not Optionable
Beta
0.72
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:IMRN) was last updated on 10/8/2025 by MarketBeat.com Staff
From Our Partners